| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |